Skip to main content
. 2023 Jun 9;102(23):e33881. doi: 10.1097/MD.0000000000033881

Table 1.

Baseline clinical and laboratory characteristics of sepsis patients.

Variables Total (N = 176) Survivors (N = 130) Non-survivors (N = 46) P value
Age (yr, IQR) 80 (72, 88) 78 (69, 87) 83 (77.75, 90) .004
Gender, n (%)
 Male 103 (58.52) 82 (63.08) 21 (45.65) .039
 Female 73 (41.48) 48 (36.92) 25 (54.35)
Comorbidity, n (%)
 Hypertension 109 (61.93) 78 (60.00) 31 (67.39) .375
 Diabetes 56 (31.82) 40 (30.77) 16 (34.78) .615
 Cardiovascular diseases 45 (25.57) 28 (21.54) 17 (36.96) .039
 Cerebrovascular diseases 54 (30.68) 33 (25.38) 21 (45.65) .010
 Chronic kidney diseases 13 (7.39) 8 (6.15) 5 (10.87) .293
 Chronic liver diseases 10 (5.68) 8 (6.15) 2 (4.35) .933
 Cancer 10 (5.68) 7 (5.38) 3 (6.52) 1.000
Primary site of infection, n (%)
 Lung infections 141 (80.11) 100 (76.92) 41 (89.13) .075
 Abdominal infections 9 (5.11) 8 (6.15) 1 (2.17) .507
 Urinary tract infections 3 (1.70) 3 (2.31) 0 (0.00) .568
 Other infections 23 (13.07) 19 (14.62) 4 (8.70) .442
APACHE II score, n (%)
 0–10 57 (32.39) 51 (39.23) 6 (13.04) .001
 11–20 89 (50.57) 62 (47.69) 27 (58.70) .200
 21–30 25 (14.20) 14 (10.77) 11 (23.91) .028
 >30 5 (2.84) 3 (2.31) 2 (4.35) .842
SOFA score, n (%)
 0–5 101 (57.39) 85 (65.38) 16 (34.78) <.001
 6–10 64 (36.36) 39 (30.00) 25 (54.35) .003
 11–15 10 (5.68) 6 (4.62) 4 (8.70) .511
 >16 1 (0.57) 0 (0.00) 1 (2.17) .586
Use of vasopressors, n (%) 67 (38.07) 28 (21.54) 39 (84.78) <.001
 RBC (×1012/L, IQR) 3.84 (3.18, 4.24) 3.96 (3.19, 4.32) 3.58 (3.06, 4.06) .059
 Hb (g/L, IQR) 116.50 (96.25, 130.00) 121.00 (96.00, 131.00) 108.00 (96.75, 122.00) .078
 WBC (×109/L, IQR) 11.26 (7.20, 15.94) 10.93 (7.08, 15.25) 12.83 (8.14, 18.17) .099
 NEUT (%, IQR) 85.10 (76.43, 90.40) 85.00 (73.40, 89.73) 86.88 (81.60, 91.98) .030
 LY (%, IQR) 7.45 (4.13, 13.08) 7.85 (4.47, 14.00) 6.10 (2.75, 10.83) .046
 PLT (×109/L, IQR) 161.00 (100.00, 232.00) 158.00 (95.00, 223.25) 163.50 (114.00, 277.50) .134
 HCT (%, IQR) 34.75 (28.30, 38.78) 35.95 (28.30, 39.28) 32.60 (28.93, 37.75) .151
 ALT (U/L, IQR) 25.00 (14.25, 47.98) 24.5 (14.00, 42.25) 29.55 (14.75, 70.25) .352
 AST (U/L, IQR) 32.00 (22.00, 60.00) 31.00 (21.23, 45.43) 37.25 (22.00, 103.48) .098
 STB (μmol/L, IQR) 17.25 (10.83, 26.78) 17.45 (10.78, 27.25) 16.60 (10.75, 25.78) .841
 BUN (mmol/L, IQR) 9.42 (5.87, 14.66) 7.92 (5.39, 12.56) 14.25 (8.99, 23.00) <.001
 Cr (μmol/L, IQR) 83.40 (57.08, 127.35) 79.25 (55.05, 124.68) 99.05 (68.90, 169.75) .020
 K (mmol/L, IQR) 3.70 (3.43, 4.30) 3.65 (3.40, 4.12) 4.10 (3.60, 4.50) .003
 Na (mmol/L, IQR) 138.15 (134.00, 143.23) 138.05 (134.00, 143.00) 138.60 (132.78, 146.48) .675
 FIB (g/L, IQR) 4.42 (3.45, 5.90) 4.41 (3.54, 6.53) 4.46 (3.25, 5.50) .689
 PT (S, IQR) 13.50 (12.40, 15.60) 13.50 (12.48, 15.10) 14.45 (12.15, 16.93) .251
 APTT (S, IQR) 30.50 (26.93, 36.88) 30.05 (26.58, 37.80) 32.30 (27.73, 36.55) .273
 D-D (mg/L, IQR) 3.04 (1.67, 6.72) 2.90 (1.57, 6.43) 3.43 (2.12, 8.22) .141
 CRP (mg/L, IQR) 65.22 (16.74, 121.19) 65.78 (16.03, 136.82) 58.11 (22.07, 105.76) .976
 PCT (ng/mL, IQR) 0.87 (0.21, 4.96) 0.78 (0.15, 5.59) 1.14 (0.34, 3.19) .304

ALT = alanine aminotransferase, APACHE II score = Acute Physiology and Chronic Health Evaluation II score, APTT = Activated Partial Thromboplastin Time, AST = aspartate aminotransferase, BUN = Blood Urea Nitrogen, Cr = Creatinine, CRP = C-reactive protein, D-D = D-dimer, FIB = fibrinogen, Hb = hemoglobin, HCT = hematocrit, K = Potassium, LY% = Lymphocyte, Na = Sodium, NEUT% = Neutrophil, PCT = Procalcitonin, PLT = platelet, PT = prothrombin time, RBC = Erythrocytes, SOFA score = Sequential Organ Failure Asses score, STB = Serum Total Bilirubin, WBC = leukocyte.